0001209191-17-016741.txt : 20170302
0001209191-17-016741.hdr.sgml : 20170302
20170302165609
ACCESSION NUMBER: 0001209191-17-016741
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170228
FILED AS OF DATE: 20170302
DATE AS OF CHANGE: 20170302
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Flexion Therapeutics Inc
CENTRAL INDEX KEY: 0001419600
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10 MALL ROAD
STREET 2: SUITE 301
CITY: BURLINGTON
STATE: MA
ZIP: 01803
BUSINESS PHONE: (781) 305-7777
MAIL ADDRESS:
STREET 1: 10 MALL ROAD
STREET 2: SUITE 301
CITY: BURLINGTON
STATE: MA
ZIP: 01803
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DRISCOLL FREDERICK W
CENTRAL INDEX KEY: 0001129890
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36287
FILM NUMBER: 17659728
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-02-28
0
0001419600
Flexion Therapeutics Inc
FLXN
0001129890
DRISCOLL FREDERICK W
C/O FLEXION THERAPEUTICS, INC.
10 MALL ROAD, SUITE 301
BURLINGTON
MA
01803
0
1
0
0
Chief Financial Officer
Common Stock
2017-02-28
4
M
0
30000
7.8861
A
41211
D
Common Stock
2017-02-28
4
S
0
32834
19.9619
D
8377
D
Common Stock
2017-02-28
4
S
0
600
20.4167
D
7777
D
Stock option (right to buy)
7.8861
2017-02-28
4
M
0
30000
0.00
D
2023-05-19
Common Stock
30000
105300
D
Includes 680 shares of Common Stock that were acquired by the Reporting Person on November 20, 2015 pursuant to the Issuer's Employee Stock Purchase Plan.
Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted December 20, 2016.
The weighted average sale price for the transaction reported was $19.9619, and the range of prices were between $19.41 and $20.40. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
The weighted average sale price for the transaction reported was $20.4167, and the range of prices were between $20.41 and $20.43. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
1/4 of the shares subject to the option vest one year after May 20, 2013, with 1/48th of the shares vesting monthly thereafter over the next 3 years.
/s/ Frederick Driscoll
2017-03-02